Literature DB >> 32557193

Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients.

Giovanni Marasco1, Elton Dajti2, Federico Ravaioli2, Luigina Vanessa Alemanni2, Fabiana Capuano3, Kamela Gjini3, Luigi Colecchia2, Giovanni Puppini4, Caterina Cusumano3, Matteo Renzulli5, Rita Golfieri5, Davide Festi2, Antonio Colecchia3.   

Abstract

BACKGROUND: Non-selective β-blocker (NSBB) therapy is the treatment of choice for primary prophylaxis of cirrhotic patients with high-bleeding risk esophageal varices (HRV). The hemodynamic response to NSBB is assessed by the measurement of the hepatic venous pressure gradient (HVPG). Recently, liver and spleen stiffness measurements (LSM and SSM) were proposed as non-invasive surrogates of HVPG. We aimed to evaluate LSM and SSM changes for assessing hemodynamic response in these patients.
METHODS: Cirrhotic patients with HRV were prospectively enrolled and evaluated at our Department before starting NSBB and after 3 months. Correlation between changes (delta) of HVPG after NSBB treatment and those of LSM or SSM by transient elastography was performed.
RESULTS: From the initial 59 patients considered for the study, 20 were finally included in the analysis. Fifteen (15) patients reached hemodynamic response to NSBB according to HVPG. Changes in LSM did not correlate with changes in HVPG (r = 0.107, p value = 0.655), unlike changes in SSM (r = 0.784, p value < 0.0001). Delta SSM presented excellent accuracy in identifying HVPG responders (AUROC 0.973; 95% CI 0.912-1). The best cut-off for delta SSM to identify responders was -10% (sensitivity 100%, specificity 60%, NPV 100% and PPV 90%).
CONCLUSIONS: SSM could be a reliable non-invasive test for the assessment of hemodynamic response to NSBB therapy as primary prophylaxis for HRV. Similar to HVPG, SSM reduction ≥ 10% is able to assess hemodynamic response.

Entities:  

Keywords:  Carvedilol; Esophageal varices; Hepatic venous pressure gradient; High-bleeding risk esophageal varices; Liver stiffness measurement; Non-invasive test; Non-selective β-blockers; Portal hypertension; Propranolol; Spleen stiffness measurement

Year:  2020        PMID: 32557193     DOI: 10.1007/s12072-020-10062-w

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  13 in total

Review 1.  A Primer to the Diagnostic and Clinical Utility of Spleen Stiffness Measurement in Patients With Chronic Liver Disease.

Authors:  Andrea Mladenovic; Raj Vuppalanchi; Archita P Desai
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-28

2.  Spleen Transient Elastography and Damping Index Identify a Subgroup of Patients Without an Acute or Chronic Response to Beta-Blockers.

Authors:  Elba Llop; Christie Perelló; Teresa Fontanilla; Juan de la Revilla; Marta Hernández Conde; Marta López; Javier Minaya; Carlos Ferre; Javier Abad; Carlos Fernández Carrillo; José Luís Martínez; Natalia Fernández Puga; María Trapero; Ismael El Hajra; Elena Santos; José Luis Calleja
Journal:  Front Med (Lausanne)       Date:  2022-06-22

3.  Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis.

Authors:  Giovanni Marasco; Elton Dajti; Matteo Serenari; Luigina Vanessa Alemanni; Federico Ravaioli; Matteo Ravaioli; Amanda Vestito; Giulio Vara; Davide Festi; Rita Golfieri; Matteo Cescon; Matteo Renzulli; Antonio Colecchia
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

4.  Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers.

Authors:  Matteo Renzulli; Nicolò Brandi; Anna Pecorelli; Luigi Vincenzo Pastore; Alessandro Granito; Giuseppe Martinese; Francesco Tovoli; Mario Simonetti; Elton Dajti; Antonio Colecchia; Rita Golfieri
Journal:  Diagnostics (Basel)       Date:  2022-03-29

5.  Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis.

Authors:  Sona Frankova; Mariia Lunova; Halima Gottfriedova; Renata Senkerikova; Magdalena Neroldova; Jozef Kovac; Eva Kieslichova; Vera Lanska; Petr Urbanek; Julius Spicak; Milan Jirsa; Jan Sperl
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

6.  Detection of liver and spleen stiffness in rats with portal hypertension by two-dimensional shear wave elastography.

Authors:  YongJian Chen; JingYun Li; Qin Zhou; GuoRong Lyu; ShiLin Li
Journal:  BMC Med Imaging       Date:  2022-04-13       Impact factor: 1.930

Review 7.  Ultrasound Elastography-Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment.

Authors:  Andrej Hari
Journal:  Medicina (Kaunas)       Date:  2021-05-21       Impact factor: 2.430

8.  Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis.

Authors:  Karen Vagner Danielsen; Jens Dahlgaard Hove; Puria Nabilou; Meng Yin; Jun Chen; Mirabella Zhao; Thomas Kallemose; Ane Søgaard Teisner; Hartwig Roman Siebner; Richard L Ehman; Søren Møller; Flemming Bendtsen
Journal:  Liver Int       Date:  2021-06-16       Impact factor: 8.754

9.  Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness.

Authors:  Elton Dajti; Giovanni Marasco; Federico Ravaioli; Luigi Colecchia; Alberto Ferrarese; Davide Festi; Antonio Colecchia
Journal:  JHEP Rep       Date:  2021-04-14

Review 10.  Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis.

Authors:  Nikolaus Pfisterer; Lukas W Unger; Thomas Reiberger
Journal:  World J Hepatol       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.